Get ahead of standard treatment for ROS1-positive cancer with new-generation therapies. Access the latest treatments with clinical trial matching.
Start Your JourneyCompliant with
You can receive a guidebook with information about genomic testing by filling out the form.
ROS1 is a gene, which is a basic unit of heredity passed down from a parent to a child. In ROS1-positive cancer, the ROS1 gene fuses with another gene. This fusion causes ROS1 to become overactive, which results in uncontrolled growth of cells that can form cancerous tumors. ROS1 fusions are not inherited, but acquired during a person’s lifetime. Other terms you may see or hear to describe ROS1 fusions include ROS1 fusion positive, ROS1 rearrangements, and ROS1 gene mutations.
ROS1 fusions are found in about 1 to 2 percent of lung cancer cases, according to the American Lung Association (ALA). Specifically, this gene fusion commonly occurs in people with a form of the disease called adenocarcinoma non-small cell lung cancer. This type of lung cancer tends to be diagnosed in younger patients who do not have a history of heavy smoking, according to the ALA.
Several other cancers are linked to ROS1 fusions, including the following:
The treatment your doctor will prescribe for ROS1-positive cancer will depend on a variety of factors, including which form of cancer you have, whether it has metastasized (or spread), and what treatment you have already received. Treatments for ROS1-positive cancers include:
We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.
Access the free matching toolMassive Bio specializes in finding clinical trials of new treatments for ROS1-positive cancers and other cancers linked to gene fusions or mutations. Patients who choose to enroll in clinical trials can receive cutting-edge treatment and high-quality care under the direction of doctors, nurses, and other healthcare professionals who are participating in research to discover new therapies for cancer. Patients can gain access to promising drugs and innovative treatments long before they’re made available to the public. If you’ve been diagnosed with ROS1-positive cancer, we’re here to help. If you aren’t sure if you have ROS1-positive cancer, that’s okay. Additional testing can help you determine your exact diagnosis.
Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.
Call +1 844 627 7246Clinical trials test the latest scientific advancements in HER2-Positive cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. HER2-Positive cancer patients can gain access to promising drugs and innovative treatments long before they're made available to the public.
Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new treatments. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important treatment option for many cancer patients.
We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.
Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.
They have a really responsive and hard-working team. It’s a great way to explore clinical cancer trials and find alternative treatments.
I reached out to Massive Bio after learning of a recent breast cancer diagnosis of a family member. From free expert clinical trial matching to patient advocate support, Massive Bio was able to provide me with the necessary resources and knowledge to provide my family member the support they needed during their cancer journey.
My father used the Virtual Tumor Board to get another treatment recommendation. The report was detailed, and the staff answered all our questions. I definitely recommend their services.
I have recommended this to colleagues for patients that could benefit from clinical trials or have exhausted their treatment options and need a second opinion. Massive Bio’s team puts great minds together to find better solutions for patients that might think they have none left.
Massive Bio’s team is amazing. They work tirelessly to help patients and providers. This company truly cares about the work they are doing and the care they are delivering.